Table 3.
Before treatment | At 2 weeks of RT | At 4 weeks of RT | At 6 weeks of RT | At 8 weeks of RT | p | |
---|---|---|---|---|---|---|
ESAS | ||||||
patients with valid data, n | 167 | 132 | 103 | 79 | 68 | <0.001 |
patients with missing data, n | 0 | 35 | 64 | 88 | 99 | |
median score (50th) | 39 | 28 | 25 | 25 | 24.50 | |
QLQ-C15-PAL | ||||||
patients with valid data, n | 167 | 132 | 103 | 79 | 68 | <0.001 |
patients with missing data, n | 0 | 35 | 64 | 88 | 99 | |
median score (50th) | 31 | 28 | 26 | 26 | 25 | |
VAS | ||||||
patients with valid data, n | 167 | 132 | 103 | 79 | 68 | <0.001 |
patients with missing data, n | 0 | 35 | 64 | 88 | 99 | |
median score (50th) | 7 | 5 | 5 | 4 | 4 |
*ESAS – Edmonton Symptom Assessment Scale; QLQ-C15-PAL – Quality of Life Questionnaire-Core 15-Palliative; VAS – visual analog scale.
†The lower the ESAS and/ or the QLQ-C15-PAL scores, the higher the quality of life. The lower the VAS score, the lower the pain.